KRAS and colorectal carcinoma: Moreover, KRAS human CRC cells treated with isothiocyanates become resistant to benzo [α]pyrene or H2O2-induced cell death upregulating AKR1C1, the enzyme responsible for the reduction of 4-HNE (Bonnesen et al., 2001).